Comment: Immunotherapy combination for advanced NSCLC
Dr Marina Garassino - National Tumour Institute, Milan, Italy
Comment: Immunotherapy combination for advanced NSCLC ( Dr Marina Garassino - National Tumour Institute, Milan, Italy )
28 Sep 2019
Comment: Front-line osimertinib significantly lengthens overall survival in EGFR...
Dr Marina Garassino - National Tumour Institute, Milan, Italy
Comment: Front-line osimertinib significantly lengthens overall survival in EGFR-mutation positive NSCLC ( Dr Marina Garassino - National Tumour Institute, Milan, Italy )
28 Sep 2019
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
Important developments in radiation oncology ( Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
New standard of care for lung cancer patients with EGFR mutations
Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA
New standard of care for lung cancer patients with EGFR mutations ( Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
Lung cancer screening and the management of the pulmonary nodule
Dr Mark Block - Memorial Healthcare System, Hollywood, FL, USA
Lung cancer screening and the management of the pulmonary nodule ( Dr Mark Block - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
Immunotherapy for lung cancer before surgery
Dr. Luis Raez - Memorial Cancer Institute, Florida, USA
Immunotherapy for lung cancer before surgery ( Dr. Luis Raez - Memorial Cancer Institute, Florida, USA )
19 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in pa...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast ...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain me...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
Gene expression in primary non-small cell lung cancer as a predictor of brain metastases ( Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel )
10 Jul 2019
Integration of DNA and RNA investigations in clinical trials: A laboratory chall...
Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA
Integration of DNA and RNA investigations in clinical trials: A laboratory challenge ( Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with ot...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
The potential of PARP inhibitors in new cancer groups and in combination with other treatments ( Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston, USA )
18 Jun 2019